RIA
KRYS icon

Regal Investment Advisors’s Krystal Biotech KRYS Stock Holding History

Regal Investment Advisors’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.45M Sell
3,913
-137
-3% -$40.9K 0.08% 256
2026
Q1 		$1.05M Sell
4,050
-310
-7% -$82.5K 0.06% 282
2025
Q4 		$1.07M Buy
4,360
+44
+1% +$9.26K 0.06% 263
2025
Q3 		$762K Sell
4,316
-118
-3% -$17.7K 0.05% 311
2025
Q2 		$609K Buy
4,434
+127
+3% +$18.7K 0.05% 315
2025
Q1 		$777K Buy
+4,307
New +$724K 0.06% 252

Other funds holding KRYS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Regal Investment Advisors's KRYS Position: Q2 2026 in Review

Regal Investment Advisors reduced its Krystal Biotech (KRYS) stake by 3.4% in Q2 2026, selling an estimated $40.9K and leaving 3,913 shares worth $1.45M. The position accounts for 0.08% of the portfolio, ranked #256.

Regal Investment Advisors first reported a position in KRYS in Q1 2025 and has held it in 6 quarters since. 423 funds tracked by Wall St. Rank hold KRYS as of Q2 2026.

  • Regal Investment Advisors held 3,913 shares of Krystal Biotech worth $1.45M as of Q2 2026.
  • Regal Investment Advisors sold 137 Krystal Biotech shares in Q2 2026, an estimated $40.9K.
  • Krystal Biotech made up 0.08% of Regal Investment Advisors's portfolio in Q2 2026, its #256 holding.
  • Regal Investment Advisors first reported a position in Krystal Biotech in Q1 2025 and has held it in 6 quarters since.
  • 423 funds tracked by Wall St. Rank held Krystal Biotech as of Q2 2026.

Based on Regal Investment Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.